Vimarsana
Biggest News Aggregation in the World

Page 12 - Adaptive Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adaptive Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adaptive Research Today - Breaking & Trending Today

Kazia Therapeutics Ltd's paxalisib now the subject of multi-drug platform study at the University Hospital, Zurich - Vimarsana News

Kazia Therapeutics Ltd's paxalisib now the subject of multi-drug platform study at the University Hospital, Zurich

Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) welcomes the news that the multi-drug GBM AGILE study in glioblastoma has opened recruitment to the paxalisib...

Kintara activates first European site of Phase II/III glioblastoma trial - Vimarsana News

Kintara activates first European site of Phase II/III glioblastoma trial

Kintara Therapeutics has activated the first European site of the VAL-083 treatment arm in the Phase II/III trial for treating glioblastoma.

Kintara Announces First European Site Activation in Switzerland in GCAR Phase 2/3 Clinical Trial for Glioblastoma - Vimarsana News

Kintara Announces First European Site Activation in Switzerland in GCAR Phase 2/3 Clinical Trial for Glioblastoma

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

Kintara Therapeutics Announces Fiscal 2022 Third Quarter Financial Results and Provides Corporate Update - Vimarsana News

Kintara Therapeutics Announces Fiscal 2022 Third Quarter Financial Results and Provides Corporate Update

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

Biohaven Reports First Quarter 2022 Financial Results and Reports Recent Business Developments - Vimarsana News

Biohaven Reports First Quarter 2022 Financial Results and Reports Recent Business Developments

Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. today announced that the companies have entered into a definitive agreement under which Pfizer...